Literature DB >> 1817186

Mortality among the offspring (F1) of atomic bomb survivors, 1946-85.

Y Yoshimoto1, W J Schull, H Kato, J V Neel.   

Abstract

We compare the mortality in the years 1946-85 in a cohort of 31,159 children born to parents one or both of whom were exposed to the atomic bombing of Hiroshima and Nagasaki (a parental gonadal dose greater than or equal to 0.01 Sv) with that in a control group of 41,069 children. The average gonadal dose for the exposed parents was 0.435 Sv. The mean age of the cohorts was 28.8 years. In the greater than or equal to 0.01 Sv dose group 1,253 deaths were observed in the subset of children both of whose parents have been assigned DS86 doses. 3.2% were attributed to cancers, 72.9% to all diseases except neoplasms. These proportions in the 0 Sv dose group were about the same. Based on a linear relative risk model, no statistically significant increase in the mortality attributable to diseases other than neoplasms is noted following parental exposure, the excess relative risk being 0.030 (+/- 0.046) per sievert based on the DS86 doses (RBE of neutrons = 20). For fatal cancer, no statistically significant effect of parental radiation dose was also observed. An analysis based on the full sample, using not only the DS86 dose group but also ad hoc dose group, yields essentially the same results as the analysis restricted to the DS86 dose group.

Entities:  

Mesh:

Year:  1991        PMID: 1817186     DOI: 10.1269/jrr.32.327

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  11 in total

1.  The sex ratio of children in relation to paternal preconceptional radiation dose: a study in Cumbria, northern England.

Authors:  H O Dickinson; L Parker; K Binks; R Wakeford; J Smith
Journal:  J Epidemiol Community Health       Date:  1996-12       Impact factor: 3.710

Review 2.  Risk calculations for hereditary effects of ionizing radiation in humans.

Authors:  F Vogel
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

3.  Cancer, infant mortality and birth sex-ratio in Fallujah, Iraq 2005-2009.

Authors:  Chris Busby; Malak Hamdan; Entesar Ariabi
Journal:  Int J Environ Res Public Health       Date:  2010-07-06       Impact factor: 3.390

4.  Lack of effects of atomic bomb radiation on genetic instability of tandem-repetitive elements in human germ cells.

Authors:  M Kodaira; C Satoh; K Hiyama; K Toyama
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

5.  Genetic analysis of children of atomic bomb survivors.

Authors:  C Satoh; N Takahashi; J Asakawa; M Kodaira; R Kuick; S M Hanash; J V Neel
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

6.  Gene expression signatures that predict radiation exposure in mice and humans.

Authors:  Holly K Dressman; Garrett G Muramoto; Nelson J Chao; Sarah Meadows; Dawn Marshall; Geoffrey S Ginsburg; Joseph R Nevins; John P Chute
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

7.  Spatiotemporal association of low birth weight with Cs-137 deposition at the prefecture level in Japan after the Fukushima nuclear power plant accidents: an analytical-ecologic epidemiological study.

Authors:  Hagen Scherb; Keiji Hayashi
Journal:  Environ Health       Date:  2020-07-09       Impact factor: 5.984

8.  Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs.

Authors:  S Izumi; K Koyama; M Soda; A Suyama
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

9.  Japanese Legacy Cohorts: The Life Span Study Atomic Bomb Survivor Cohort and Survivors' Offspring.

Authors:  Kotaro Ozasa; Eric J Grant; Kazunori Kodama
Journal:  J Epidemiol       Date:  2018-03-17       Impact factor: 3.211

10.  A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer.

Authors:  Jun Nagano; Kiyohiko Mabuchi; Yasuhiko Yoshimoto; Yuzo Hayashi; Nobuo Tsuda; Charles Land; Kazunori Kodama
Journal:  J Epidemiol       Date:  2007-05       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.